Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Oncologic Safety of Nipple Sparing Mastectomy in Women With High Penetrance Germline Pathogenic Variants in Breast Cancer Susceptibility Genes

NCT06888388 is registered in ClinicalTrials.gov with Sir Mortimer B. Davis - Jewish General Hospital as lead sponsor.

NCT NCT06888388
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06888388 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Oncologic Safety of Nipple Sparing Mastectomy in Women With High Penetrance Germline Pathogenic Variants in Breast Cancer Susceptibility Genes
Lead sponsor
Sir Mortimer B. Davis - Jewish General Hospital
Phase
Observational
Overall status
Recruiting
Start date
February 1, 2025
Completion date
February 1, 2028
Enrollment
4,700 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer surgery